{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:59:44Z","timestamp":1777874384477,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jvoice.2024.09.038","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T12:48:50Z","timestamp":1729082930000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Laryngeal Myasthenia Gravis in Voice Patients: Clinical, Serologic, and Neuromuscular Characterization of Seronegative Patients for Antibodies Against the Acetylcholine Receptor and Muscle-Specific Kinase"],"prefix":"10.1016","author":[{"given":"Katherine D.","family":"Mullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Mozzochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary J.","family":"Hawkshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Sataloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2024.09.038_bib1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jvoice.2024.09.038_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jvoice.2024.09.038_bib3","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1172\/JCI66039","article-title":"Antibodies against low-density lipoprotein receptor\u2013related protein 4 induce myasthenia gravis","volume":"123","author":"Shen","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jvoice.2024.09.038_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archneur.62.3.442","article-title":"Striational antibodies in myasthenia gravis: reactivity and possible clinical significance","volume":"62","author":"Romi","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib5","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvoice.2024.09.038_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.916098","article-title":"Sorting nexin 17 increases low-density lipoprotein receptor-related protein 4 membrane expression: a novel mechanism of acetylcholine receptor aggregation in myasthenia gravis","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib7","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jvoice.2024.09.038_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0030-6665(20)31699-6","article-title":"Neuromuscular disorders","volume":"20","author":"Neal","year":"1987","journal-title":"Otolaryngol Clin N Am"},{"key":"10.1016\/j.jvoice.2024.09.038_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00159","article-title":"Myasthenia gravis with antibodies against muscle specific kinase: an update on clinical features, pathophysiology and treatment","volume":"13","author":"Cao","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jvoice.2024.09.038_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0385-8146(12)80022-8","article-title":"Myasthenia gravis poses a diagnostic problem for the otolaryngologist a closer look at symptoms may alert the possibility of myasthenia gravis","volume":"17","author":"Clongsusuek","year":"1990","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2024.09.038_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jns.2007.03.019","article-title":"Dysphonia as a primary manifestation in myasthenia gravis (MG): a retrospective review of 7 cases among 1520 MG patients","volume":"260","author":"Liu","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jvoice.2024.09.038_bib12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archotol.1975.00780380047012","article-title":"Myasthenia gravis focal to the larynx: report of a case","volume":"101","author":"Neiman","year":"1975","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.09.038_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.anl.2006.11.007","article-title":"A case report of myasthenia gravis localized to the larynx","volume":"34","author":"Kanemaru","year":"2007","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.jvoice.2024.09.038_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/jnnp.2007.135319","article-title":"Dyspnoea due to vocal fold abduction paresis in anti-MuSK myasthenia gravis","volume":"79","author":"Sylva","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jvoice.2024.09.038_bib15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/thx.51.1.108","article-title":"Myasthenia gravis presenting with stridor","volume":"51","author":"Hanson","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.jvoice.2024.09.038_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/NRL.0000000000000339","article-title":"MuSK myasthenia gravis presenting with bilateral vocal cord abduction paresis: a case report and literature review","volume":"26","author":"Santilli","year":"2021","journal-title":"Neurologist"},{"key":"10.1016\/j.jvoice.2024.09.038_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0892-1997(01)00012-1","article-title":"Laryngeal myasthenia gravis: report of 40 cases","volume":"15","author":"Mao","year":"2001","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.09.038_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jvoice.2016.07.022","article-title":"Laboratory evaluation of vocal fold paralysis and paresis","volume":"31","author":"White","year":"2017","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.09.038_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-musk antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jvoice.2024.09.038_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjoto.2018.11.002","article-title":"Clinical features of laryngeal myasthenia gravis: a case series","volume":"40","author":"Yang","year":"2019","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis: myasthenia gravis B cells","volume":"57","author":"Yi","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jvoice.2024.09.038_bib22","doi-asserted-by":"crossref","DOI":"10.21037\/atm-19-363","article-title":"Serological diagnosis of myasthenia gravis and its clinical significance","volume":"11","author":"Li","year":"2023","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jvoice.2024.09.038_bib23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.otc.2007.05.007","article-title":"Laryngeal electromyography","volume":"40","author":"Heman-Ackah","year":"2007","journal-title":"Otolaryngol Clin N Am"},{"key":"10.1016\/j.jvoice.2024.09.038_bib24","unstructured":"Skeie G.O., Aarli J.A., Gilhus N.E. Muscle autoantibodies in subgroups."},{"key":"10.1016\/j.jvoice.2024.09.038_bib25","article-title":"Three types of striational antibodies in myasthenia gravis","volume":"2011","author":"Suzuki","year":"2011","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jvoice.2024.09.038_bib26","first-page":"45","article-title":"Comparison of diagnostic tests in myasthenia gravis","volume":"19","author":"Nicholson","year":"1983","journal-title":"Clin Exp Neurol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib27","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00405-015-3663-0","article-title":"Nomenclature proposal to describe vocal fold motion impairment","volume":"273","author":"Rosen","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2006","journal-title":"Neuromuscular Disord"},{"key":"10.1016\/j.jvoice.2024.09.038_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1223322","article-title":"Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.790941","article-title":"Comorbid autoimmune diseases in patients with myasthenia gravis: a retrospective cross-sectional study of a Chinese cohort","volume":"12","author":"Shi","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jvoice.2024.09.038_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards","volume":"55","author":"Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jvoice.2024.09.038_bib32","first-page":"1","article-title":"Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics","volume":"82","author":"Rodrigues","year":"2024","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"10.1016\/j.jvoice.2024.09.038_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16022","article-title":"Clinical characteristics, and treatment outcomes in patients with double-seronegative myasthenia gravis","volume":"31","author":"Martinez-Harms","year":"2023","journal-title":"Eur J Neurol."}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089219972400331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089219972400331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:44:23Z","timestamp":1777578263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089219972400331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":33,"alternative-id":["S089219972400331X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2024.09.038","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laryngeal Myasthenia Gravis in Voice Patients: Clinical, Serologic, and Neuromuscular Characterization of Seronegative Patients for Antibodies Against the Acetylcholine Receptor and Muscle-Specific Kinase","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2024.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of The Voice Foundation.","name":"copyright","label":"Copyright"}]}}